139 related articles for article (PubMed ID: 25830298)
1. Modulation of recombinant antigenic constructs containing multi-epitopes towards effective reduction of atherosclerotic lesion in B6;129S-Ldlr(tm1Her)Apob(tm2Sgy)/J mice.
Xia M; Chen D; Endresz V; Lantos I; Szabo A; Kakkar V; Lu X
PLoS One; 2015; 10(4):e0123393. PubMed ID: 25830298
[TBL] [Abstract][Full Text] [Related]
2. Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob(tm2Sgy)Ldlr(tm1Her)J mice.
Lu X; Xia M; Endresz V; Faludi I; Szabo A; Gonczol E; Mundkur L; Chen D; Kakkar V
Atherosclerosis; 2012 Nov; 225(1):56-68. PubMed ID: 22959702
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.
Lu X; Xia M; Endresz V; Faludi I; Mundkur L; Gonczol E; Chen D; Kakkar VV
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2358-71. PubMed ID: 22837469
[TBL] [Abstract][Full Text] [Related]
4. Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development.
Xia M; Chen D; Endresz V; Faludi I; Szabo A; Gonczol E; Kakkar V; Lu X
PLoS One; 2013; 8(12):e81056. PubMed ID: 24349031
[TBL] [Abstract][Full Text] [Related]
5. Immune regulation by oral tolerance induces alternate activation of macrophages and reduces markers of plaque destabilization in Apob
Thota LN; Ponnusamy T; Philip S; Lu X; Mundkur L
Sci Rep; 2017 Jun; 7(1):3997. PubMed ID: 28638138
[TBL] [Abstract][Full Text] [Related]
6. Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.
Mundkur L; Mukhopadhyay R; Samson S; Varma M; Kale D; Chen D; Shivaprasad S; Sivanandan H; Soman V; Lu X; Kakkar VV
PLoS One; 2013; 8(3):e58364. PubMed ID: 23505495
[TBL] [Abstract][Full Text] [Related]
7. Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice.
Lu X; Chen D; Endresz V; Xia M; Faludi I; Burian K; Szabo A; Csanadi A; Miczak A; Gonczol E; Kakkar V
Atherosclerosis; 2010 Oct; 212(2):472-80. PubMed ID: 20609438
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.
Gisterå A; Hermansson A; Strodthoff D; Klement ML; Hedin U; Fredrikson GN; Nilsson J; Hansson GK; Ketelhuth DF
J Intern Med; 2017 Apr; 281(4):383-397. PubMed ID: 28194913
[TBL] [Abstract][Full Text] [Related]
9. Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.
Rao LN; Ponnusamy T; Philip S; Mukhopadhyay R; Kakkar VV; Mundkur L
Lipids; 2015 Aug; 50(8):785-97. PubMed ID: 26178198
[TBL] [Abstract][Full Text] [Related]
10. Activation of inflammatory cells and cytokines by peptide epitopes in vitro: a simple in-vitro screening assay for prioritizing them for in-vivo studies.
Mundkur LA; Varma M; Shivanandan H; Krishna D; Kumar K; Lu X; Kakkar VV
Inflamm Res; 2013 May; 62(5):471-81. PubMed ID: 23400302
[TBL] [Abstract][Full Text] [Related]
11. Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor.
Uchiyama R; Hasegawa H; Kameda Y; Ueda K; Kobayashi Y; Komuro I; Takano H
J Mol Cell Cardiol; 2012 May; 52(5):1038-47. PubMed ID: 22285481
[TBL] [Abstract][Full Text] [Related]
12. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
[TBL] [Abstract][Full Text] [Related]
13. Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
Gonçalves I; Nitulescu M; Ares MP; Fredrikson GN; Jansson B; Li ZC; Nilsson J
Atherosclerosis; 2009 Jul; 205(1):96-100. PubMed ID: 19150065
[TBL] [Abstract][Full Text] [Related]
14. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis.
Thota LN; Ponnusamy T; Lu X; Mundkur L
Cardiovasc Drugs Ther; 2019 Aug; 33(4):385-398. PubMed ID: 31332656
[TBL] [Abstract][Full Text] [Related]
17. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice.
Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK
Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717
[TBL] [Abstract][Full Text] [Related]
18. Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice.
Mundkur L; Ponnusamy T; Philip S; Rao LN; Biradar S; Deshpande V; Kumar R; Lu X; Kakkar VV
Int J Cardiol; 2014 Aug; 175(2):340-51. PubMed ID: 24962340
[TBL] [Abstract][Full Text] [Related]
19. Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.
Dimayuga PC; Zhao X; Yano J; Lio WM; Zhou J; Mihailovic PM; Cercek B; Shah PK; Chyu KY
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28711866
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
